The formulation is more specific than its botanical label
The ingredient declaration includes progesterone, pregnenolone and Tripeptide-29, as well as emollients, other base ingredients and botanical materials. Lavender and lemongrass ingredients also appear. Naming these components is useful for identifying the proposed preparation, but it does not establish their concentration or how much a particular application delivers. Source 1
The seller describes laboratory conversion in the wild-yam origin story for progesterone. A source material and the final ingredient are different details: a cream containing named progesterone cannot accurately be summarized merely as a wild-yam extract. The cosmetic-versus-prescription guide explains why a familiar skincare format does not settle the identity or medical implications of what it contains.
The public record leaves dose and exposure unresolved
We did not verify a concentration for the two hormonal ingredients, a measured dose per pump or pharmacokinetic testing of the marketed cream. Those omissions limit a comparison with any prescribed hormone preparation. They cannot be repaired by treating the package size, application-count estimate or a customer testimonial as an absorption measurement. Source 1
The manufacturer itself says the product may influence hormones and advises discussion with a healthcare provider. A useful conversation would concern the complete preparation and existing care, not merely whether wild yam sounds natural. Our hormone-test discussion provides related context without suggesting that a consumer test can independently decide whether this product is appropriate.
Cosmetic wording does not establish regulatory approval
FDA explains that a product’s intended use and claims help distinguish a cosmetic from a drug. A seller’s placement in a skincare category is therefore not, by itself, proof of a particular approval status or a guarantee of negligible systemic effects. This review did not verify FDA approval for the finished Balance formula. Source 2
We also do not infer that all topical preparations containing a hormone have identical evidence, exposure or risk. The claims guide keeps a named ingredient, a mechanism story and evidence for a particular preparation apart. A clinical finding for estriol or another hormone product should not be imported into this cream’s review to fill an unresolved formula question.
The lower amount belongs to a recurring selection
The inspected page showed $54.95 for one-time purchase and $47.26 alongside two- and three-month subscription delivery choices. These are purchase arrangements, not proof of how long a container will last for a particular buyer. The frequency of a shipment should not be interpreted as medical guidance or a validated duration of benefit. Source 1
The page also offered a $6.99 priority option. That describes an order service rather than access to a prescribing clinician or guaranteed advice about hormones. The price guide encourages preserving the full order summary. We did not confirm checkout charges, the exact renewal notice or the time required to change a recurring shipment.
A guarantee headline needs its applicable terms
The product page advertises a sixty-day guarantee, but this review did not independently inspect a complete eligibility record sufficient to promise a refund after opening. That is a concrete evidence limit. It would be misleading to present the marketing headline as an unconditional reimbursement of product cost, delivery charges and any return postage. Source 1
The offer was described as available within the United States. We did not place a domestic order or establish service availability for any particular address. Before relying on the guarantee, ask when its clock starts, which purchases qualify and whether a recurring shipment is treated differently. Keep those commercial questions distinct from the medical discussion about the ingredients.
Bring a complete product record to the decision
An informed discussion would include the actual label, the intended use, other hormone-containing products and the unresolved concentration information. We do not recommend adding Balance to a prescription, replacing a treatment or following a dosing cycle described in promotional material. Public ingredient and order pages do not supply an individualized assessment.
AAD’s general advice about testing new skincare concerns skin reactions; it does not determine whether hormonal exposure is appropriate. That limit matters here because surface comfort and systemic effects are different questions. Balance’s record is useful for identifying named ingredients and purchase choices, while suitability, delivered amounts and clinical outcomes require evidence beyond the retail page. Source 3